AstraZeneca plc
AZN.L
LATEST TRADE
8,291.00GBP
CHANGE
-6.00(-0.07%)
VOLUME
394,293
TODAY'S RANGE
8,285.00 - 8,357.00
52 WEEK RANGE
6,499.80 - 8,848.00
As of 4:50 AM PDT Aug 04 on the London Stock Exchange (LON) ∙ Minimum 15 minute delay
Previous Close8,297.00
Open8,337.00
Volume401,765
3M AVG Volume51.05
Today's High8,357.00
Today's Low8,285.00
52 Week High8,848.00
52 Week Low6,499.80
Shares Out (MIL)1,549.12
Market Cap (MIL)128,225.10
Forward P/E22.06
Dividend (Yield %)2.44
8/4/2021
8,264
AZN.L
8,264
Advanced Charting
Next Event
Dividend For AZN.L - 64.8000 GBXAug 12, 2021
Latest Developments
More
3 days ago
AstraZeneca Says Saphnelo Approved In US For Moderate To Severe Systemic Lupus Erythematosus
7 days ago
AstraZeneca Says Half-Year COVID-19 Revenue Jumped To Nearly $1.2 Bln
8 days ago
Hutchmed (China) Says Co And Astrazeneca Initiate Phase II Trial Of Orpathys
About AstraZeneca plc
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). It has approximately 38 projects in Phase I, including 26 new molecular entities (NMEs), and 12 oncology combination projects. It has approximately 43 projects in Phase II, including 25 NMEs; six additional indications for projects that have reached phase II, and 12 oncology combination projects. It has approximately 22 projects in late-stage development, either in Phase III/pivotal Phase II studies or under regulatory review.
INDUSTRY
Biotechnology & Drugs
CONTACT INFO
1 Francis Crick Avenue
CB2 0AA
United Kingdom
+44.20.73045000
https://www.astrazeneca.com/Home
EXECUTIVE LEADERSHIP
Leif Johansson
Independent Non-Executive Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin
Chief Financial Officer, Executive Director
Jeffrey A. Pott
Chief Human Resource Officer, General Counsel
Katarina Ageborg
Executive Vice President - Sustainability, Chief Compliance Officer
Key Stats
1.86 mean rating - 29 analysts
SELLHOLDBUY
REVENUE (MM, USD)
2018
22.1K
2019
24.4K
2020
26.6K
2021(E)
33.5K
EPS (USD)
2018
3.460
2019
3.500
2020
4.020
2021(E)
5.233
Price To Earnings (TTM)40.20
Price To Sales (TTM)6.04
Price To Book (MRQ)9.64
Price To Cash Flow (TTM)26.31
Total Debt To Equity (MRQ)175.40
LT Debt To Equity (MRQ)156.93
Return On Investment (TTM)8.22
Return On Equity (TTM)5.64
Latest News
Barbie debuts doll in likeness of British COVID-19 vaccine developer
British coronavirus vaccine developer Sarah Gilbert has many science accolades to her credit but now shares an honor with Beyonce, Marilyn Monroe and Eleanor Roosevelt: a Barbie doll in her likeness.
5 hours ago
Chilean study shows variations in success of COVID-19 vaccines
Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7%...
15 hours ago
Combining AstraZeneca and mRNA COVID-19 vaccines is effective -Danish study
Combining AstraZeneca's COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna's jab provides "good protection", Denmark's State Serum Institute said on Monday.
2 days ago
Cambodia to mix vaccines as booster shots to fight COVID
Cambodia will begin offering a booster shot against Covid-19, switching between the AstraZeneca and Chinese COVID-19 vaccines in an effort to fight the spread of the coronavirus in the Southeast Asian country.
4 days ago
First COVID-19 vaccines donated by Britain head to Guyana and Belize
The first contingent of COVID-19 vaccines donated by Britain to help tackle the pandemic around the world left London's Heathrow airport on Friday bound for Guyana and Belize, the government said.
5 days ago
Mixing Russia's Sputnik V, AstraZeneca shots proves safe in small trial -RDIF
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca's shot revealed no serious side effects and no subsequent cases of coronavirus among volunteers, the Russian Direct Investment Fund (RDIF) said on Friday.
6 days ago
Mixing Russia's Sputnik V, AstraZeneca shots proves safe in small trial -RDIF
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca's vaccine revealed no serious side effects among volunteers, the Russian Direct Investment Fund (RDIF) said on Friday.
6 days ago
Thailand renews COVID-19 vaccination drive for monks at risk
Thailand began a renewed drive to vaccinate Buddhist monks and other temple workers in Bangkok against the coronavirus on Friday, as the country battles its most deadly surge in infections since the pandemic began.
6 days ago
Japan OKs administration of AstraZeneca shots after delay - media
Japan on Friday approved the administration of AstraZeneca Plc's COVID-19 vaccine after a few months' pause due to fears about potential side effects, local media reported.
6 days ago
BRIEF-Emergent Says Working With AstraZeneca On Documentation For US Govt COVID-19 Vaccine Dose Shipments: Conf Call
* EMERGENT SAYS WORKING WITH ASTRAZENECA ON DOCUMENTATION FOR US GOVERNMENT COVID-19 VACCINE DOSE SHIPMENTS: CONF CALL
6 days ago
Exclusive - AstraZeneca exploring options for COVID-19 vaccine business - executive
AstraZeneca is exploring options for the future of its COVID-19 vaccine and expects greater clarity on the matter by the end of 2021, a senior executive said on Thursday, following a series of setbacks in its race to produce a shot for the world.
6 days ago
AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
Second-quarter sales of AstraZeneca's COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker on Thursday again delayed its U.S. application for approval as it gathers more data for submissions.
6 days ago
Exclusive - AstraZeneca COVID-19 vaccine shipped to Canada, Mexico before adequate plant inspections
Canada and Mexico imported millions of doses of AstraZeneca's COVID-19 vaccine and offered them to the public without health officials properly inspecting the operations of the U.S. manufacturer, according to inspection records and the regulators involved.
6 days ago
AstraZeneca hopes to settle EU legal dispute in coming weeks -exec
AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially ending a row that has dogged the drugmaker and Brussels this year.
6 days ago
EXCLUSIVE-AstraZeneca exploring options for COVID-19 vaccine business - executive
* AstraZeneca to have clarity on future of vaccines by year-end
6 days ago
AstraZeneca CEO hopeful COVID-19 vaccine may still have role in U.S
AstraZeneca still plans to seek U.S. approval for its COVID-19 vaccine even though the process there is taking longer than expected, because it may still be used in the country in the future, CEO Pascal Soriot said on Thursday.
7 days ago
EXCLUSIVE-AstraZeneca exploring options for COVID-19 vaccine business, exec says
AstraZeneca is exploring options for the future of its COVID-19 vaccine business and expects greater clarity on the matter by the end of 2021, a senior executive told Reuters on Thursday.
7 days ago
EXCLUSIVE-AstraZeneca COVID-19 vaccine shipped to Canada, Mexico before adequate plant inspections
Canada and Mexico imported millions of doses of AstraZeneca's COVID-19 vaccine and offered them to the public without health officials properly inspecting the operations of the U.S. manufacturer, according to inspection records and the regulators involved.
7 days ago
EXCLUSIVE-AstraZeneca exploring options for COVID-19 vaccine business, exec says
AstraZeneca is exploring its options for the future of its COVID-19 vaccine business and expects greater clarity on the matter by the end of 2021, a senior executive told Reuters on Thursday.
7 days ago
AstraZeneca hopes to settle EU legal dispute in coming weeks - exec
AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially ending a row that has dogged the drug maker and Brussels this year.
7 days ago
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.
Apps​Newsletters​Advertise with UsAdvertising Guidelines​Cookies​Terms of UsePrivacyDo Not Sell My Personal Information
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All Rights Reserved.
Olympics-Another record on track, Belarus sprinter heads for Poland and the fastest woman in the world can’t outrun TV rights